As I write this, the Rays are sixth in the American League in our in-house playoff odds. They’re two and a half games out of first place in the American League East, and they’re one game out of a wild-card spot. This year’s Rays have a chance to actually go somewhere. This year’s Mets do not, and so a sensible trade has been made.

Rays get:

• Lucas Duda

Mets get:

• Drew Smith

This is one of those easy ones, one of those simple ones, one of those ones that hardly even warrants a write-up at all. The Mets are out of the race, and Duda is an aging rental player. Smith is a minor-league reliever, and for all I know those might be literally a dime a dozen, but he has plus velocity and an interesting curve, so you never know when it might click. The Rays, meanwhile, found themselves interested by the improvement Duda could provide. What is a Lucas Duda? This is a Lucas Duda.

Duda is a player whose very name kind of suggests everything you need to know about him. Not that I necessary mean to profile, and I don’t condone this sort of activity, but the name “Lucas Duda” conveys a certain amount of size and power. Duda, indeed, is large and strong, and he presently ranks among the league leaders in average exit velocity. The pluses are that he can hit the ball far, and he’s also comfortable drawing a walk. On the downside, Duda’s not much of a defender, and he’s prone to his strikeouts. He’s historically been a lot better against both righties and starting pitchers, so there are holes in his swing to be exploited.

Duda isn’t an impact rental in the way that J.D. Martinez could be an impact rental. Duda’s not that good. Still, he is a legitimate masher, and he’s an offensive upgrade over, say, Brad Miller, who’s been DHing too much. Duda, now, will slide into that spot, allowing Corey Dickerson to more regularly play the outfield while Miller could go back to pairing with Tim Beckham. There’s also a chance Miller or Beckham could subsequently be dealt — the Rays are tricky like that. But mostly, this feels like an addition for the sake of extra versatility and dingers. The roster will be stretched a little less thin, and in even better news, Kevin Kiermaier is nearing his return from the disabled list.

The Rays aren’t going for it in the traditional sense, and I doubt they ever will. They genuinely can’t afford to make those kinds of moves. But they are still clearly acting on their present opportunity, as they’ve also recently added players like Dan Jennings, Sergio Romo, and Chaz Roe. Those are three unspectacular relievers, yet there are things to like about each, and the Rays added them cheaply. They’re short-term additions, intended to make the Rays better now, but they haven’t actually lost very much. Smith is a recent third-round pick, but you don’t sweat dealing most A-ball relievers.

Duda’s going to serve as a two-month slugger. If things go the Rays’ way, he’ll be more like a three-month slugger. It might be moderately troubling that he, Dickerson, and Logan Morrison are all left-handed, but there’s still time to patch up the bench. The Rays are for real as a competitive team, and they’re adding for now in the way that makes sense to them. It’s hardly exciting, hardly dramatic, but the Rays are banking on their usual formula. They’re not a team that makes splashes. They just want to make sure they’re okay.

With Zack Wheeler joining the Mets’ small army of pitchers on the disabled list, the team will turn to 23-year-old Chris Flexen tonight against the Padres. Unless you’re a Mets fan with a deep interest in prospects, there’s a good chance this is your first time hearing Flexen’s name. I’ll admit that I was unaware of him until a couple of days ago when I came across his name while formatting KATOH’s most recent top-100 list.

But despite his obscurity, Flexen has undeniably earned this opportunity with the way he’s pitched this season. He started the year on the DL after having a bone chip removed from his right knee, but has been utterly dominant since returning. In three High-A starts, he pitched to a 2.81 xFIP with a 25% strikeout rate. He was even better in Double-A, spinning a 2.43 xFIP thanks to a 29% strikeout rate.

It’s been a long slog for Flexen, who was originally drafted by the Mets in the 12th round way back in 2012. After a couple of lackluster seasons in the lower levels, he underwent Tommy John Surgery in 2014. He pitched decently in 2016, his first full year after the surgery, but did so with a sub-17% strikeout rate. There was little reason to suspect he was on the verge of a breakout in 2017.

Eric Longenhagen included Flexen in his preseason Mets list, but only in the “Honorable Mention” section. He saw him as being worse than a 40 FV — the equivalent of a spot starter or middle reliever.

He sits 91-94, touching 96, with an average curveball and fringe change. He has a big, sturdy, inning-eating frame but has already had a surgery, and there are scouts who’d like to see if the fastball plays consistently at 96 out of the ‘pen . Others think he’s more of an up-and-down starter.

Eric provided an updated scouting snippet last month.

He has been 92-96, flashing an above-average slider and throwing all four of his pitches for strikes.

Because of scouts’ pessimism, there’s a sizable gap between Flexen’s stats-only KATOH forecast and KATOH+, which incorporates his (lack of) preseason prospect rank. The stats-only version projects him for 5.6 WAR over his first six years, which is good for 66th overall and 13th among pitchers. But that forecast drops to a meager 2.8 WAR once the scouting data is layered in. KATOH+ sees him as a near-certain fringe-player.

And since it looks noticeably different, I also made a stats-only graph. This one gives him a much more realistic chance of racking up more than 4 WAR.

To put some faces to Flexen’s statistical profile, let’s generate some statistical comps. I calculated a Mahalanobis distance between Flexen’s 2017 numbers and every historical season since 1991. In the table below, you’ll find the 10 most similar seasons, ranked from most to least similar. The WAR totals refer to each player’s first six seasons in the major leagues. Please note that the Mahalanobis analysis is separate from KATOH. KATOH relies on macro-level trends, rather than comps. The fates of a few statistically similar players shouldn’t be used to draw sweeping conclusions about a prospect’s future. For this reason, I recommend using a player’s KATOH forecast to assess his future potential. The comps give us some interesting names that sometimes feel spot-on, but they’re mostly just there for fun.

It’s tough to know what to make of Flexen. While his small-sample 2017 numbers have been exceptional, he’s never pitched anywhere near this well before, nor was he ever seen as much of a prospect. But then again, this might simply be an instance of Flexen finally being healthy for the first time in at least three years. I look forward to watching tonight to see how he fares against big-league hitters.

Daily notes on prospects from lead prospect analyst Eric Longenhagen. Read previous installments here.

Dominic Smith, 1B, New York NL (Profile)
Level: Triple-A Age: 22   Org Rank:  3 Top 100: 73
Line: 3-for-5, 2B, 2 HR
Notes
Most developmental paths are long and winding, but Smith has been robotically effective since his first full pro season. He has made hard, all-fields contact each year, his home parks always tossing his slugging figures around. Even his year-to-year batted-ball profile has been consistent. He’s a high-probability regular with a chance to be a three-plus-win player if the glove scouts see shows up on paper.

Read the rest of this entry »

Former Mets pitcher Anthony Young died Tuesday after a fight with cancer, an inoperable brain tumor, at 51.

Teammates say he was known for his dignity and grace, characteristics he demonstrated through what his career is remembered for: losing 27 consecutive decisions between the 1992 and 1993 seasons, the longest streak in major-league history.

He died on the anniversary of his 24th consecutive loss on June 27, 1993, which set the major-league record.

Read the rest of this entry »

Coming into the season, Michael Conforto saw opportunity with the Mets despite a crowded outfield. He seized his chance early in the year and was among the majors’ best players in April and May. Then the league made an adjustment, one with which he’s struggling to adjust back. You could call that regression. You could also just call it baseball — as the player himself did recently with a shrug — but that ebb and flow is important. He needs to figure out this latest puzzle to get back on track.

Read the rest of this entry »

Daily notes on prospects from lead prospect analyst Eric Longenhagen. Read previous installments here.

Thomas Szapucki, LHP, New York NL (Profile)
Level: Low-A  Age: 21   Org Rank: 7   Top 100: NR
Line: 6 IP, 2 H, 2 BB, 0 R, 10 K

Notes
Szapucki missed all of April and May with a shoulder injury. Sunday was his fourth start of the year and he worked more efficiently and missed more bats than he had in his previous three appearances. Szapucki already boasts a plus fastball/curveball combination and he’s a potential No. 3 starter if he can develop a changeup and/or plus command of his breaking ball. Should he fail to, then there’s some concern that Szapucki’s low-3/4 arm slot might be an issue against upper-level right-handed hitters and limit his effectiveness and role. He’s had a back and shoulder issue during his pro career and made many starts on extended rest. Sunday’s came with a full week between starts.

Read the rest of this entry »

We live in an era of home runs. You know that. It’s been discussed ad nauseam on your favorite team’s broadcast, on your Twitter feed, and by your favorite baseball writers. We’re going to talk about it some more now.

The cause for this spike is manifold. Players are swinging up and for the fences, as you may have heard. They’re better-conditioned and better-fed. We understand the science and kinetics of hitting better than ever. The ball is quite possibly juiced. It’s a perfect storm of dingeritis that’s led to a fascinating new world where it’s not just guys like Aaron Judge and Paul Goldschmidt who are in scoring position the very second they step into the box. Well over 100 batters have hit at least 10 home runs, and we’re not out of June yet. The list grows to more than 240 batters if you include those who have hit at least 5, which means they’ve got a fair shot of getting to double digits before the season is out.

So yeah, we’re going coo-coo for Cocoa Puffs here. Which leads to an interesting question: if this continues, if the ball really is juiced and if players are going to keep chasing fly balls when they’re in the box, if anyone can hit the ball out, doesn’t that make a home run less special? Doesn’t that make a home run less valuable? Doesn’t it alter projections for amateurs and prospects?

There’s two important lines of thought there, so we’ll tackle the inside-baseball stuff first. If you’re running a baseball team, you’re probably no longer getting worked up over a free agent with 20-homer power because of his power alone. Why dish out a two- or three-year deal for a veteran when there are kids in your minor-league system who can replicate that kind of power on the cheap? Power was one of the last remaining calling cards of free agents. Defense and speed can decrease with time, but veterans could get paid for their bats. Rookies and journeymen like Yonder Alonso are suddenly tapping into previously unrecognized reservoirs of power with wild success. Not everyone has a Cody Bellinger sitting around at Triple-A, but given the way the ball is flying around and the way hitters are structuring their swings, you may be able to scrounge up 15 bombs for a league-minimum salary.

We already saw some of this over the winter when players like Chris Carter had a hard time finding work. Power is coming even easier now. It’s becoming less of a defining tool. If everyone can hit 15-20 bombs, it then becomes a question of what else a player can do for you, and for how much. Can you field well? Can you play multiple positions? Do you walk a lot? Can you do all that for cheap?

There’s more to this than team-building and the squeezing out of veterans, too. There’s a fan’s side to this too, and it’s probably more important. We’re now witnessing home runs more often than ever. Mark McGwire, Barry Bonds and Sammy Sosa aren’t running around out there anymore. The word “anabolic” isn’t in the papers all that often anymore. This is more dramatic than the steroid era. Maybe we’ll one day call this the “uppercut era,” the “juiced-ball era,” or the “three-true-outcomes era.” But this is clearly a different animal. Balls that have never really gone out before are going out. Is there a saturation point?

Read the rest of this entry »

Daily notes on prospects from lead prospect analyst Eric Longenhagen. Read previous installments here.

Breiling Eusebio, LHP, Colorado (Profile)
Level: Short Season  Age: 20   Org Rank: NR   Top 100: NR
Line: 5 IP, 4 H, 0 BB, 1 R, 7 K

Notes
It’s been a strong 2017 affiliate debut for Eusebio, who looked quite good throughout extended spring training, his fastball often sitting 90-94 with some tail. His low-70s curveball improved as we inched closer to the summer and it, too, was missing bats as June arrived and is currently average, flashing above. Eusebio has trouble timing his delivery, which can negatively impact his command, but he’s deceptive, throws hard for a lefty starting-pitching prospect, and has breaking-ball feel. Very much a prospect.

Read the rest of this entry »

The Mets were supposed to be good. Heading into the season, we projected them for 87 wins, a bit behind the NL’s elite trio, but solidly among the top teams that were expected to contend for a playoff spot. With Yoenis Cespedes back in the fold and a strong pitching staff led by a dynamite rotation, expectations were high.

Then, everyone got hurt. Seth Lugo and Steven Matz couldn’t make it out of spring training, thinning the team’s expected rotation depth. Lucas Duda and Wilmer Flores went down at the same time in April, leaving the team without a real infield. Cespedes got hurt a week later, then Noah Syndergaard’s arm started hurting a few days after that. Travis d’Arnaud injured his wrist in the first week of May. Jeurys Familia developed a blod clot not long after. Asdrubal Cabrera hurt his thumb.

Even the guys who aren’t officially hurt might not be healthy. Matt Harvey‘s stuff has backed up to the point that he doesn’t really miss bats anymore, and now looks like a back-end starter. Robert Gsellman’s spin rates have nosedived, and his effectiveness has gone with it. Jose Reyes isn’t hurt, but given his 53 wRC+ and below-average defense at third base, the team would be better if he were.

Read the rest of this entry »

Daily notes on prospects from lead prospect analyst Eric Longenhagen. Read previous installments here.

Michael Paez, INF, New York NL (Profile)
Level: Low-A   Age: 22   Org Rank: NR   Top 100: NR
Line: 4-for-5, HR

Notes
Paez was the best prospect on Coastal Carolina’s 2016 College World Series championship team. He’s 5-foot-8 but has sneaky pull power to which he’s always been able to get in games despite high strikeout totals. He’s 22 and a college hitter at Low-A so his season .306/.404/.543 line needs to be taken with a large grain of salt, but he could be a big-league bench piece as a power-before-hit infielder who can play second and third base.

Read the rest of this entry »